Gabriel Herrero-Beaumont Cuenca
Picture 369Picture 369

Dr. Gabriel Herrero-Beaumont Cuenca

Jefe de Servicio de Reumatología | Madrid
Reumatología

CV Médicos con centros Gabriel Herrero-Beaumont Cuenca

Información general

Experiencia

Jefe de Servicio (desde 1998)

Titulación
  • Profesor Titular de Reumatología.
  • Doctor en Medicina

Investigación y docencia

  • Director del Laboratorio de Investigación de Patología Osteoarticular.
  • Encargado de la asignatura de Reumatología en la Facultad de Medicina de la UAM. Profesor titular de Reumatología

Publicaciones

Desde 1982 hasta 2011: 124 publicaciones

En 2012-2013 ha realizado otras 21 publicaciones:

  • Andrés-Bergós J, Tardio L, Larranaga-Vera A, Gómez R, Herrero-Beaumont G, Largo R. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem. 2012 Sep 28;287(40):33615-28. Epub 2012 Aug 2. PubMed PMID: 22859309; PubMed Central PMCID: PMC3460460.
  • Lugo L, Villalvilla A, Gómez R, Bellido M, Sánchez-Pernaute O, Largo R, Herrero-Beaumont G, Roman-Blas JA. Effects of PTH [1-34] on synoviopathy in an experimental model of osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage. 2012 Dec;20(12):1619-30. doi: 10.1016/j.joca.2012.08.010. Epub 2012 Aug 27. PubMed PMID: 22935787
  • Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. Arthritis Res Ther. 2012 Jun 18;14(3):R149. doi: 10.1186/ar3884. PubMed PMID: 22709525; PubMed Central PMCID: PMC3446534.
  • Almagro MI, Roman-Blas JA, Bellido M, Castañeda S, Cortez R, Herrero-Beaumont G. PTH [1-34] enhances bone response around titanium implants in a rabbit model of osteoporosis. Clin Oral Implants Res. 2012 May 25. doi: 10.1111/j.1600-0501.2012.02495.x. [Epub ahead of print] PubMed PMID: 22626278.
  • Castañeda S, Martínez Calatrava MJ, Herrero-Beaumont G. [Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept]. Rev Clin Esp. 2012 May;212(5):244-54. doi: 10.1016/j.rce.2011.09.008. Epub 2011 Dec 15. Review. Spanish. PubMed PMID: 22176928.
  • Herrero-Beaumont G, Martínez Calatrava MJ, Castañeda S. Abatacept mechanism of action: concordance with its clinical profile. Reumatol Clin. 2012 mar-Apr;8(2):78-83. doi: 10.1016/j.reuma.2011.08.002. Epub 2011 Nov 21. Review. PubMed PMID: 22104048.
  • Castañeda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2012 Feb 1;83(3):315-23. doi: 10.1016/j.bcp.2011.09.018. Epub 2011 Sep 22. Review. PubMed PMID: 21964345.
  • Sanchez-Pernaute O, Filkova M, Gabucio A, Klein M, Maciejewska-Rodrigues H, Ospelt C, Brentano F, Michel BA, Gay RE, Herrero-Beaumont G, Gay S, Neidhart M, Juengel A. Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts Ann Rheum Dis published 12 December 2012, 10.1136/annrheumdis-2012-201906
  • Pérez Esteban S, Herrero-Beaumont G. Osteoimmunology, osteorheumatology or rheumatology alone? Reumatol Clin. 2013 May 2. doi:pii: S1699-258X(13)00061-2. 10.1016/j.reuma.2013.03.002. PMID: 23643640
  • Acebes C, Romero FI, Contreras MA, Mahillo I, Herrero-Beaumont G. Dynamic ultrasound assessment of medial meniscal subluxation in knee osteoarthritis. Rheumatology (Oxford). 2013 Apr 16. [Epub ahead of print] PMID:23594469
  • Castañeda S, Roman-Blas JA, Cohen-Solal M, Largo R, Herrero-Beaumont G. Is lecturing in Rheumatology Satellite Symposia a male attribute? Rheumatol Int. 2013 Apr 16. [Epub ahead of print] PMID: 23588408
  • Henrotin Y, Chevalier X, Herrero-Beaumont G, McAlindon T, Mobasheri A, Pavelka K, Schön C, Weinans H, Biesalski H; Participants at the Hohenheim Consensus Conference in August 29th 2011.Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities. BMC Res Notes. 2013 Mar 26;6:115. doi: 10.1186/1756-0500-6-115. PMID: 23531101
  • Navarro-Sarabia F, Herrero-Beaumont G. Viscosupplementation for osteoarthritis of the knee. Ann Intern Med. 2013 Jan 1;158(1):74-5. doi: 10.7326/0003-4819-158-1-201301010-00019. PMID: 23277908
  • Gómez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G. LCN2 a new catabolic adipokine produced by human osteoblasts. Submitting for publication. Annals of the Rheumatic Diseases. A. IF: 8.727
  • Gómez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G. LCN2 a new adipokine involved in bone and cartilage crosstalk. 2013. Submitting for publication. Arthritis and Rheumatism. A. IF:7.866.
  • Villalvilla A, da Silva JA , Largo R, Gualillo O, Vieira PC, Herrero-Beaumont G, Gómez R: 6-Shogaol inhibits chondrocytes’ innate immune responses and cathepsin-K activity. Molecular Nutrition and Food Research. 2013. Under second revision. A. IF: 4.301
  • Prieto-Potín I, Roman-Blas JA, Martínez-Calatrava MJ, Gómez R, Largo R, Herrero-Beaumont G. Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration. Arthritis Research Therapy. En prensa.
  • Castañeda S, Roman-Blas J, Largo R, Herrero-Beaumont G. Osteoarthritis is a progressive disease with changing phenotypes. Rheumatology. En prensa.
  • Vicente E, Herrero-Beaumont G, Castañeda S. Update on the use of abatacept for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology. En prensa.
  • Roman-Blas JA, Castañeda S, Largo R, Lems W, Herrero-Beaumont G. An OA phenotype(s) may obtain major benefit from bone acting agents. Sem Arthritis Rheum. Under first revision.
  • Herrero-Beaumont G, Roman-Blas J. Osteoporotic OA: a reasonable target for bone acting agents. Nature Review Rheumatology. En prensa.

Comunicaciones y ponencias

Desde 1985 hasta 2011: 140 comunicaciones

En 2012-2013:

  • Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas J, Tardio L, Largo R, Herrero-Beaumont G. Rankl produced by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 32st European Workshop for Rheumatology Research (EWRR) Workshop. Ann Rheum Dis 2012;71(Suppl1): A68.
  • Villalvilla A, Almada J, Vieira PC, Largo R, Herrero-Beaumont G, Gómez R. Shogaol inhibits cathepsin-K activity and has anti-catabolic and anti-inflammatory properties in stimulated chondrocytes. 32st European Workshop for Rheumatology Research (EWRR) Workshop. Ann Rheum Dis 2012;71(Suppl1): A68.
  • Andrés-Bergós J, Tardío L, Villalvilla A, Gómez R, Herrero-Beaumont G, Largo R. O-GLCNAC protein modification stimulates chondrogenesis in vitro and chondrocyte hypertrophy in mouse. 32st European Workshop for Rheumatology Research (EWRR) Workshop. Ann Rheum Dis 2012;71(Suppl1): A71.
  • Subchondral bone remodelling and osteoarthritis. Román-Blas J, Castañeda S, Largo R, Herrero-Beaumont G. Proceedings of Osteorheumatology 2011: International Congress on Bone Involvement in Arthritis. Santa Margherita Ligure, Italy. 13-14 October 2011. Arthritis Research & Therapy 2012, 14(Suppl 2):A6.
  • Prieto-Potin, M. J. Martínez-Calatrava, J. A. Román-Blas, R. Largo, L. Tardío, G. Herrero-Beaumont. Rankl produced by articular chondrocytes induces bone loss associated with arthropathies. Osteoathritis Cartilage 2012; 20: S65.
  • Herrero-Beaumont G, Tardío L, Gómez-Barrena E, Andrés J, Largo R. Identification of an extracelular O-N-acetyl-glycosylase responsable forn an increased level of O-linked N-acetylglucosamine modified proteins in the cartilage of patients with osteoarthritis. Osteoathritis Cartilage 2012; 20: S6118.
  • Largo R, Tardío L, Andrés J, Herrero-Beaumont G. Study of the O-N-GlucNac of proteins induced by high doses of glucosamine and its correlation with osteroarthritis progression. Osteoathritis Cartilage 2012; 20: S6126.
  • Lugo, L, Villalvilla A, Gómez R, Largo R, Herrero-Beaumont G. Functional estrogen biosynthesis machinery is expressed in human postmenopausic osteoarthritis chondrocytes. Osteoathritis Cartilage 2012; 20: S141.
  • Andrés J, Tardío L, Villalvilla A, Gómez-Barrena E, Herrero-Beaumont G, Largo R. O-N-GlcNac protein modification stimulates chondrogenesis in vitro and chondrocyte hypertrophy in mouse. Osteoathritis Cartilage 2012; 20: S6150.
  • Navarro F, Toyos J, Herrero-Beaumont G, Coronel P, Gimeno M, Hernández Cruz B. Knee joint space width progression: Results of a 3,3 years randomized, doublé blind clinical trial with hyaluronic acid. Osteoathritis Cartilage 2012; 20: S6168.
  • Perez-Ferro M, Recuero S, Romero F, Serrano C, Rodriguez-Nieto M, Gomez-Seco J, Presa T, Godo J, Gabriel Herrero-Beaumont G, Sanchez-Pernaute O. Effect of Repeated Infusions of Rituximab in Patients with Primary Sjögren’s Syndrome. Arthritis Rheum 2012; 64: S749-S750.
  • Prieto-Potin I, Martínez-Calatrava MJ, Román-Blas JA, Tardio L, et al. Does RANKL produced by articular chondrocytes actively participate in juxta-articular bone loss related to chronic arthritis? Bone 2012; 50: S97.
  • Tardio L, Andrés-Bergós J, Herrero-Beaumont G, Largo R. Study of the O-linked-N-acetyl-glucosaminylation of proteins induced by high doses of glucosamine and its correlation with osteoarthritis progression. Bone 2012; 50: S99.
  • Villalvilla A, Gómez R, Largo R, Herrero-Beaumont G, et al. Human articular chondrocytes from elderly osteoarthritic woman synthesize local estradiol through steroidogenesis reactions catalyzed by aromatase and 17beta-hydroxysteroid dehydrogenase. Bone 2012; 50: S95.
  • Villalvilla A, Silva JA, Cezar P, Largo R, Herrero-Beaumont G. Anti-inflammatory and anti-resoptive properties of ginger derivatives. Bone 2012; 50: S99.
  • Andrés-Bergós J, Tardío L, Villalvilla A, Gómez R, Largo R, Herrero-Beaumont G. O-GlcNAc protein modification stimulates chondrogenesis in vitro and chondrocyte hypertrophy in mouse. Bone, 2012 Bone; 50: S119.
  • Ferreiro-Iglesias A, Calaza M, Perez-Pampin E, Lopez-Longo FJ, Marenco JL, Blanco F, Narvaez J, Navarro F, Cañete JD, Herrero-Beaumont G, et al. Genomics, genetic basis of disease and replication of interactions between polymorphisms in rheumatoid arthritis susceptibility. Ann Rheum Dis 2013; 72(Suppl3): 165
  • Castañeda S, Guede D, Caeiro JR, Roman-Blas J, Largo R, Herrero-Beaumont G. Transitional zones displacement of the subchondral bone layers in a model of osteoporosis and osteoarthritis in rabbits. Ann Rheum Dis 2013; 72(Suppl3): 381
  • Loricera J, Blanco R, Castañeda S, Umbría A, Melchor S, Rubio R, Calvo-Alen J, Aurrecoechea E, Rúa-Figueroa I, Ortego N, Minguez M, Herrero-Beaumont G et al. Biologic therapy in aortitis: a multicenter study of 30 patients. Ann Rheum Dis 2013; 72(Suppl3): 030

Consulta el contenido multimedia de este profesional.

En qué hospitales atiende este profesional

Pide cita en el centro o consulta más información.

CV Médicos con centros Gabriel Herrero-Beaumont Cuenca

Artículos de

Consulta los últimos artículos en Tu canal de salud.

No tienes seguro de saludNo tienes seguro de salud

¿No tienes seguro de salud?

Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.